Chemoinformaics analysis of 2,2-DIMETHYL-3-(2-METHYLPROP-1-ENYL)CYCLOPROPANE-1-CARBOXYLIC ACID
| Molecular Weight | 168.236 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 17 |
| Exact Molecular Weight | 168.115 | nRing | 1 |
| Solubility: LogS | -3.559 | nHRing | 0 |
| Solubility: LogP | 2.251 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.9727 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.735 |
| Synth | 2.21 |
| Natural Product Likeliness | 0.71 |
| NR-PPAR-gamma | 0.673 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.004 |
| HIA | 0.03 |
| CACO-2 | -4.87 |
| MDCK | 0.0000313 |
| BBB | 0.445 |
| PPB | 0.919465 |
| VDSS | 0.841 |
| FU | 0.0714502 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.974 |
| CYP2c19-inh | 0.607 |
| CYP2c19-sub | 0.838 |
| CYP2c9-inh | 0.671 |
| CYP2c9-sub | 0.868 |
| CYP2d6-inh | 0.425 |
| CYP2d6-sub | 0.86 |
| CYP3a4-inh | 0.383 |
| CYP3a4-sub | 0.423 |
| CL | 2.793 |
| T12 | 0.441 |
| hERG | 0.034 |
| Ames | 0.786 |
| ROA | 0.24 |
| SkinSen | 0.476 |
| Carcinogencity | 0.883 |
| EI | 0.813 |
| Respiratory | 0.731 |
| NR-Aromatase | 0.49 |
| Antiviral | No |
| Prediction | 0.931393 |